Clinical Trial

Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura

Name: Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura — clinical trial record (NCT07093606)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated July 30, 2025 (before its estimated January 20, 2026 completion). Its status may not reflect the trial's current state.

Summary

this study amis to assess the incidence and severity of liver dysfunction in ITP patients receiving eltrombopag.

Trial Details

NCT Number	NCT07093606
Lead Sponsor	Sohag University
Conditions	ITP - Immune Thrombocytopenia
Enrollment	100 participants
Start Date	2025-07-14
Primary Completion	2026-01-20 (estimated)
Study Completion	2026-01-20 (estimated)
Updated on ClinicalTrials.gov	2025-07-30